Clincosm LogoSign in Get a demo

Biogeography of the Oral Microbiome

Sponsor
Viome (Industry)
Overall Status
Completed
CT.gov ID
NCT05672953
Collaborator
(none)
20
Enrollment
1
Location
2.7
Actual Duration (Months)
7.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A cross-sectional study to metatranscriptomically analyze and compare the oral microbiome in different environmental niches within the oral cavity.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study will collect samples from participants meeting the eligibility criteria over the span of 3 months. Samples will be collected from multiple locations within the oral cavity and metatranscriptomically analyzed.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    20 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Biogeography of the Oral Microbiome Using Metatranscriptomic Analyses
    Actual Study Start Date :
    May 20, 2021
    Actual Primary Completion Date :
    Aug 10, 2021
    Actual Study Completion Date :
    Aug 10, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Species richness in multiple oral locations [3 months]

      Number of species present in different areas swabbed in the oral cavity.

    Secondary Outcome Measures

    1. KO richness of multiple oral locations [3 months]

      KO richness of multiple areas swabbed in the oral cavity.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • 18 years old or older
    Exclusion Criteria:

    • Positive SARS-CoV-2 test result, if performed

    • Antibiotic use in the previous 30 days

    • Mouthwash use in the previous 6 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Viome Life Sciences Bothell Washington United States 98011

    Sponsors and Collaborators

    • Viome

    Investigators

    • Principal Investigator: Momchilo Vuyisich, Viome
    • Principal Investigator: Guruduth Banavar, Viome

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Viome
    ClinicalTrials.gov Identifier:
    NCT05672953
    Other Study ID Numbers:
    • V243
    First Posted:
    Jan 5, 2023
    Last Update Posted:
    Jan 5, 2023
    Last Verified:
    Dec 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jan 5, 2023